Covered recipient · General Payments record
COREY SARACENI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2023
$764.70
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $282.82 | 17 |
| Education | $99.00 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $166.26 | 6 |
| ABBVIE INC. | $106.72 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.85 | 2 |
| QOL Medical, LLC | $40.99 | 3 |
| Celgene Corporation | $24.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.00 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825205 | CMS |
| AbbVie Inc. | $18.00 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825209 | CMS |
| AbbVie Inc. | $16.23 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825213 | CMS |
| AbbVie Inc. | $19.87 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825217 | CMS |
| AbbVie Inc. | $13.13 | 06/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825221 | CMS |
| AbbVie Inc. | $23.49 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998825225 | CMS |
| Celgene Corporation | $24.00 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015050593 | CMS |
| Janssen Biotech, Inc. | $10.30 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988093963 | CMS |
| Janssen Biotech, Inc. | $13.41 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988093973 | CMS |
| Janssen Biotech, Inc. | $99.00 | 03/06/2023 | Education | Undisputed | 01/23/2026 | 988093951 | CMS |
| Janssen Biotech, Inc. | $13.94 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988093983 | CMS |
| Janssen Biotech, Inc. | $11.18 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988093995 | CMS |
| Janssen Biotech, Inc. | $18.43 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988094005 | CMS |
| QOL Medical, LLC | $14.50 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059268329 | CMS |
| QOL Medical, LLC | $13.49 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059268325 | CMS |
| QOL Medical, LLC | $13.00 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059268323 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.65 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055584063 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.20 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055584069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.